Cargando…
What is the new target inhibiting the progression of Alzheimer's disease
To stop the progression of Alzheimer's disease in the early stage, it is necessary to identify new therapeutic targets. We examined striatal-enriched phosphatase 61 expression in the brain tissues of 12-month-old APPswe/PSEN1dE9 transgenic mice. Immunohistochemistry showed that al-enriched phos...
Autores principales: | Zhang, Lin, Yang, Jing, Cao, Yunpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145903/ https://www.ncbi.nlm.nih.gov/pubmed/25206502 http://dx.doi.org/10.3969/j.issn.1673-5374.2013.21.002 |
Ejemplares similares
-
Estrogen receptor beta treats Alzheimer's disease
por: Tian, Zhu, et al.
Publicado: (2013) -
Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013) -
Is transcranial direct current stimulation a potential method for improving response inhibition?☆
por: Kwon, Yong Hyun, et al.
Publicado: (2013) -
Neuropeptide Y gene transfection inhibits post-epileptic hippocampal synaptic reconstruction
por: Zhang, Fan, et al.
Publicado: (2013) -
Divalent cation tolerance protein binds to β-secretase and inhibits the processing of amyloid precursor protein☆
por: Liu, Runzhong, et al.
Publicado: (2013)